Fondaparinux (2.5mg) Injection

Fondaparinux (2.5mg) Injection is a synthetic anticoagulant medication used to prevent and treat serious blood clots such as deep vein thrombosis (DVT) and pulmonary embolism. This pharmaceutical product belongs to the class of selective Factor Xa inhibitors and plays a crucial role in reducing the risk of clot-related complications, especially after major orthopedic or abdominal surgeries.

Fondaparinux 2.5mg works by specifically blocking Factor Xa, an essential component in the blood coagulation pathway. Inhibiting this factor prevents the formation and growth of blood clots without directly affecting platelets. The injection is administered subcutaneously under medical supervision, ensuring accurate dosing and effective anticoagulation management.

Fondaparinux (2.5mg) supports safe blood circulation and lowers the risk of stroke, DVT, and pulmonary embolism. It is widely used in hospital settings for both prevention and treatment of thromboembolic disorders. Regular monitoring and proper medical guidance are essential to ensure optimal safety and therapeutic outcomes.

Product Features

• Contains Fondaparinux Sodium 2.5mg
• Selective Factor Xa inhibitor
• Prevents and treats DVT and pulmonary embolism
• Effective post-surgical clot prevention
• Administered via subcutaneous injection

How It Helps

• Prevents the formation of harmful blood clots
• Reduces risk of post-surgical thrombosis
• Supports healthy blood circulation
• Lowers the risk of pulmonary embolism